LRRK2-IN-12 (compound 1) inhibits the activity of LRRK2 G20195 ( IC 50 =0.45 nM), LRRK2 WT ( IC 50 =1.1 nM) and LRRK2 WT ADP-Glo ( IC 50 =0.46 nM). LRRK2-IN-12 can be used for Alzheimer's Disease research .
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Autophagy | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > LRRK2
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.